ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Randomized Phase III Study of Exemestane (Aromasin) for 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed by Exemestane

This study is ongoing, but not recruiting participants.
Study NCT00036270.   Last updated on November 22, 2008.   Information provided by Pfizer

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:
1 Conditions listed in this trial
Breast Neoplasms
2 More general conditions related to this trial
Breast Diseases
Neoplasms
Neoplasms by Site
Skin Diseases
3 Interventions listed in this trial
exemestane (Aromasin)
tamoxifen + exemestane
4 Additional drug interventions recognized in this trial
Exemestane
Tamoxifen
5 More general drug interventions related to this trial
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Aromatase Inhibitors
Bone Density Conservation Agents
Enzyme Inhibitors
Estrogen Antagonists
Estrogen Receptor Modulators
Hormone Antagonists
Hormones, Hormone Substitutes, and Hormone Antagonists
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Selective Estrogen Receptor Modulators
Therapeutic Uses
6 Sponsors listed in this trial
Pfizer




Links to all studies - primarily for crawlers